There is urgent need for rapid, point of care diagnostic tools for tuberculosis (TB) and drug sensitivity. Current methods based on in vitro growth take weeks, while DNA amplification can neither differentiate live from dead organisms nor determine phenotypic drug resistance. Here we show the development and evaluation of a rapid breath test for isoniazid (INH)-sensitive TB based on detection of labeled N 2 gas formed specifically from labeled INH by mycobacterial KatG enzyme. In vitro data shows the assay is specific, dependent on mycobacterial abundance, and discriminates between INH-sensitive and resistant (S315T mutant KatG) TB. In vivo, the assay is rapid with maximal detection of 15 N 2 in exhaled breath of infected rabbits within five to ten minutes. No increase in 15 N 2 is detected in un-infected animals, and the increases in 15 N 2 are dependent on infection dose. This test may allow rapid detection of INH-sensitive TB.
Introduction
Bacterially-activated prodrugs are unusually well-represented among the first-and secondline TB drugs. These include not only established drugs such as isoniazid 1 , ethionamide 2 or pyrazinamide 3 , but also newly approved and developing agents such as the nitroimidazoles delamanid 4 and PA-824 5 . The selectivity of these agents arises from their specific activation by mycobacterial enzymes, usually to reactive intermediates, and is underlined by the major mode of resistance to these agents being mutations in genes of their activating enzymes such as katG for INH 6 , ethA for ethionamide 7 , pncA for pyrazinamide 8 and ddn for nitroimidazoles 9 . Since gene inactivation may occur through a multiplicity of single nucleotide polymorphisms (SNPs) or insertion/deletion (indel) events, nucleic acid amplification and SNP-indel detection approaches provide only partially predictive drug susceptibility data. Beyond single gene mutational resistance, multiple other alleles [10] [11] [12] [13] [14] and other drugs 15, 16 may influence enzymatic activity of prodrug conversion, factors that may also limit nucleic acid based techniques for drug susceptibility testing. Despite the importance of prodrug activation, studies have been limited to in vitro samples or bacterial culture, and at present there are no POC techniques to directly measure prodrug conversion and enzymatic activity.
The mycobacterial enzyme KatG, which is responsible for INH activation, produces a range of INH-derived radicals that react with cellular components, especially the isonicotinoyl acyl radical (INAcyl) that adds covalently to NAD + and NADP + . The adducts formed by these radicals are potent inhibitors of key mycobacterial targets. The first target of such inhibition to be elucidated was 2-trans-enoyl-acyl carrier protein reductase (InhA) which binds INacyl-NAD + adducts tightly inhibiting mycolic acid synthesis 17 . Although other targets or reactive species may play roles, the importance of these alternative mechanisms compared to the widely accepted inhibition of InhA remains unclear 18 .
The detection of degradation products of the INacyl-NAD + adduct, such as 4-isonicotinoylnicotinamide (4-INN) in urine or other fluids held great promise as a measure of INH prodrug conversion in TB, and so determining KatG activity 19 . However, this appears to lack specificity for M. tuberculosis as 4-INN was found in urine of uninfected mice treated with INH, and in urine of TB patients even when they were culture-negative after treatment 19 .
Mycobacterial KatG activates INH by oxidation to a hydrazyl radical that undergoes beta scission to form INAcyl radical. The other product of this beta-scission reaction, diazene, has received little to no attention in the literature. To study diazene production in KatG expressing mycobacteria, we used doubly 15 N 2 -hydrazyl labeled INH (1) to produce doubly labeled diazene (Fig. 1A) . Under physiologic conditions this diazene rapidly undergoes either oxidation by unsaturated bonds (Figure 1b) 20 23, 24 . Rabbits were infected with high dose (10 4 CFU) or low dose (10 3 CFU) M. tuberculosis H37Rv using an inhalation exposure system (Glas-col) as previously described 25 . After a six week incubation period, rabbits were treated with 10 mg of 15 N 2 -hydrazyl INH instilled bronchoscopically. Direct delivery to the lung was chosen to rapidly expose lung bacteria to 15 N 2 -hydrazyl INH in order to allow rapid assay, as opposed to an oral dosage form which would require absorption and redistribution. Inhaled INH has been used clinically in humans. 26 Breath samples were collected prior to dosing, and then at 5, 10 and 20 minutes post-dose. Four non-infected rabbits were used as control group.
It was seen that δ 15 N 2 increased rapidly in breath of all infected animals, with no observed increase in breath δ 15 N 2 of the four uninfected controls (Fig. 5A , 5B). The lack of signal in uninfected animals, together with significant signals in all infected animals, suggests that a high degree of sensitivity and specificity is inherent in this assay. Breath δ 15 N 2 reached a maximum after 5 to 10 minutes, and then variably decreased, likely due to differential distribution and absorption of 15 N 2 -hydrazyl INH from the lung into systemic circulation from the more focal pattern of delivery arising from instillation. A relationship between peak levels of δ 15 N 2 and lung CFU was observed ( Fig. 6A and 6B reflecting δ 15 N 2 as a function of lung CFU at sacrifice and initial infective CFU respectively). This suggests the approach might be sensitive to the amount of lung mycobacteria present, although significant further work is needed to delineate this relationship. Repetitive use of the technique is also likely to be complicated by the highly bactericidal nature of inhaled INH, and for monitoring of bacterial load other techniques such as urease breath tests 23 or sputum CFU may be more useful.
Discussion
The 33 ) further studies of specificity are planned.
Similar approaches may also be extended to other TB prodrug classes so that effective and rapid detection of drug sensitivity/resistance through prodrug conversion can guide therapy. One example would be Delamanid and PA824 that are activated to bactericidal NO· by mycobacterial Ddn 5 : using 15 N-nitro-PA824 would result in 15 NO· that could be directly detected in breath, or as 15 N-nitrate/nitrite in other samples such as blood or urine. This could provide rapid detection of drug activation (and hence sensitivity) in patients when conventional techniques such as MS detection of des-nitro-PA824 are difficult (Clif Barry, personal communication). This would allow optimal use of these drugs in therapy of multidrug resistant (MDR) and extensively-drug resistant (XDR) disease.
More generally, while pathogen genotypes are rapidly determined without culture, the study of bacterial phenotypes in the host (as opposed to culture in which it can greatly change) is extremely challenging. However, the broad importance of phenotype and phenotype variance in pathogenesis is becoming increasingly appreciated, with specific examples of both growth phase-dependent 34 and stochastic 35 isoniazid resistant phenotypes being recently elucidated. The ability to determine bacterial phenotypes through stable isotope detection of specific bacterial metabolic pathways without requiring culture could prove broadly valuable in complementing genomic approaches in studying microbiomes. Finally, it is worth noting that yet another reactive species from mycobacterial KatG activation of INH, in this case diazene, could play a role in INH action through reducing key unsaturated mycobacterial molecules.
Methods

Bacterial cultures
Mycobacterium tuberculosis-H37Rv (H37Rv), M. bovis BCG, E.coli DH5α and P. aeruginosa PAO1 were gifts from Professor Vojo Deretic, 37, 38 M. tuberculosis katGS315T (katG-S315T) was a gift from Professor Alex Pym 36 . S. aureus USA300 LAC was a gift from Professor Pamela Hall 39 . All bacterial cultures were grown at 37°C with shaking. Mycobacterium cultures were prepared by thawing frozen stock aliquots: H37Rv and katG-S315T were grown in 7H9 Middlebrook liquid medium supplemented with oleic acid, albumin, dextrose and catalase (Becton Dickinson, Inc., Sparks, MD), 0.5% glycerol and 0.05% Tween 80. BCG was grown in the same culture medium omitting oleic acid. Escherichia coli DH5α was grown overnight in LB broth (Becton Dickinson), Pseudomonas aeruginosa strain PAO1 was grown overnight in LB broth supplemented with 1.76% NaCl and 1% glycerol, and Staphylococcus aureus USA300 LAC was grown overnight in BBL Trypticase soybroth (Becton Dickinson).
In vitro KatG assay
3 ml of mycobacterial cultures (BCG, H37Rv or katG-S315T) were diluted as appropriate from week-old cultures, while other bacterial cultures (P. aeruginosa, E. coli or S. aureus) were diluted from overnight cultures. The 3 ml cultures were shaken aerobically and then were incubated with 15 N 2 -hydrazyl INH (at 0.1 mg/ml unless noted) in 12 ml Exetainer vials (Labco Ltd., Ceredigion, UK) for 1 hour at 37 with shaking at 250 rpm unless otherwise indicated. Collected headspace gas (1 ml) was filtered through 0.25 micron syringe filters and transferred into Helium-flushed Exetainers.
Measurement of 15 N 2 conversion
Sampled gas was analyzed for 15 N enrichment in headspace N 2 by gas isotope ratio mass spectrometry (Delta plus XL, Thermo Scientific Inc. Waltham, MA). Samples were separated by GC immediately upstream of their inlet into the IRMS using a 30 m column packed with 5 Å molecular sieves operating at 60°C and using ultra high purity helium as carrier gas. IRMS of the N 2 peak measured relative ratio of mass 30 15 N 2 vs. mass 28 14 N 2 . Nitrogen gas of purity >99.99% (Matheson Tri-Gas, Albuquerque, NM) was used as reference gas.
Animal experiments
These consisted of four uninfected control rabbits, two rabbits infected at high dose (N3 and N4) and two rabbits infected at low dose (N5 and N6). Rabbits (females, 16-20 weeks old, 3.5 -4 Kg pathogen-free outbred New Zealand White, Robinson Services, Inc., Mocksville, NC) were aerosol infected with M. tuberculosis H37Rv at either 10 3 or 10 4 CFUs using an inhalation exposure system as previously described 40 (Glas-col, Terre Haut, IN). At week 6, rabbits were anesthetized with ketamine 15-25 mg/kg and xylazine 5-10 mg/kg, and then 10 mg 15 N 2 -hydrazyl-INH in 0.4 ml saline was instilled using intra-tracheal insertion through an endotracheal tube. To collect breath gas, a 14-French feeding tube connected to a 30 ml syringe was introduced through the endotracheal tube into the level of the carina to aspirate the exhaled air when rabbit is breathing out. Breath gas (12 ml) was filtered with a 0.35-micron filter into Helium-flushed tubes before and after 15 N 2 -hydrazyl-INH treatment at 0, 5, 10, and 20 min. 15 N 2 enrichment in breath gas was measured by IRMS. Immediately after breath testing, the animals were euthanized, and lung weight and CFU measured (Table 1 . Rabbits were euthanized with intravenous euthasol (Virbac Corporation, Fort Worth, TX). The rabbit model was chosen as it is the smallest model that enables ready endoscopic infection, instillation of INH, and collection of breath.
Ethics statement
Animal work in this study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health, the Animal Welfare Act and US federal law. The protocol was approved by the Institutional Animal Care and Use Committees at Johns Hopkins University (RB11M466).
Statistical analysis
All statistical analyses were performed using SPSS version 19 (SPSS Inc., Chicago, IL). P values were determined using ANOVA and Students' t-test, and values <0.05 considered statistically significant. hydrazyl INH administration. Data represent mean ± STD (n=3 repeats for each rabbit N3 through N6, n=12 for four uninfected control rabbits with 3 repeats for each). Two-way mixed ANOVA with Bonferroni post hoc test. *p<0.001. See detailed rabbit data in Table 1 . 
